Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-12

Clinical Trial Update: Retrospective Study of IBS-D Patients Previously Receiving SBI

View source ↗

Summary

A completed retrospective study examining outcomes in diarrhoea-predominant irritable bowel syndrome patients who had previously received SBI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SBI

Snippet

Sponsor: Entera Health, Inc | Conditions: Diarrhoea Predominant Irritable Bowel Syndrome | Status: COMPLETED